Search research articles
Contact Us
Filters
Showing results (481-490 of 595) with videos related to
Page
of 60
Sort By:
Diabetes Care
|
November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruption
A J Scheen, P Henrivaux, B Jandrain, et al.
Diabete & Metabolisme
|
January 1, 1988
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man
N Paquot, A J Scheen, P Franchimont, et al.
Acta Endocrinologica
|
November 1, 1987
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion
M Castillô, A J Scheen, G Paolisso, et al.
Revue Medicale De Liege
|
May 17, 2002
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]
A J Scheen, N Paquot, B Jandrain, et al.
Revue Medicale De Liege
|
April 7, 2017
[Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER]
A J Scheen, L Piérard, J-M Krzesinski, et al.
Revue Medicale De Liege
|
March 22, 2019
[Management of hypertriglyceridaemia]
A J Scheen, C Wallemacq, J De Flines, et al.
Diabetes & Metabolism
|
December 19, 2016
Factors associated with reaching or not reaching target HbA<sub>1c</sub> after initiation of basal or premixed insulin in patients with type 2 diabetes
A J Scheen, H Schmitt, H H Jiang, et al.
Revue Medicale De Liege
|
February 11, 2010
[Management of an obese person with metabolic syndrome]
M Rorive, J De Flines, N Paquot, et al.
Revue Medicale De Liege
|
August 1, 2009
[Monoclonal antibodies in diabetes: almost approaching the dream?]
J C Philips, B Keymeulen, C Mathieu, et al.
Revue Medicale De Liege
|
August 6, 2010
[Strategies avoiding inertia and non compliance in clinical trials]
B J Jandrain, Ph Ernest, R P Radermecker, et al.
Page
of 60
Search research articles
Search
Showing results (481-490 of 595) with videos related to
Sort By:
Page
of 60
Diabetes Care
|
November 1, 1987
U-100 insulin gives some protection against metabolic deterioration due to CSII interruption
A J Scheen, P Henrivaux, B Jandrain, et al.
Diabete & Metabolisme
|
January 1, 1988
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man
N Paquot, A J Scheen, P Franchimont, et al.
Acta Endocrinologica
|
November 1, 1987
The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion
M Castillô, A J Scheen, G Paolisso, et al.
Revue Medicale De Liege
|
May 17, 2002
[Postprandial hyperglycemia. I. Physiopathology, clinical consequences and dietary management]
A J Scheen, N Paquot, B Jandrain, et al.
Revue Medicale De Liege
|
April 7, 2017
[Cardiovascular and renal protection of patients with type 2 diabetes : focus after EMPA-REG OUTCOME and LEADER]
A J Scheen, L Piérard, J-M Krzesinski, et al.
Revue Medicale De Liege
|
March 22, 2019
[Management of hypertriglyceridaemia]
A J Scheen, C Wallemacq, J De Flines, et al.
Diabetes & Metabolism
|
December 19, 2016
Factors associated with reaching or not reaching target HbA<sub>1c</sub> after initiation of basal or premixed insulin in patients with type 2 diabetes
A J Scheen, H Schmitt, H H Jiang, et al.
Revue Medicale De Liege
|
February 11, 2010
[Management of an obese person with metabolic syndrome]
M Rorive, J De Flines, N Paquot, et al.
Revue Medicale De Liege
|
August 1, 2009
[Monoclonal antibodies in diabetes: almost approaching the dream?]
J C Philips, B Keymeulen, C Mathieu, et al.
Revue Medicale De Liege
|
August 6, 2010
[Strategies avoiding inertia and non compliance in clinical trials]
B J Jandrain, Ph Ernest, R P Radermecker, et al.
Page
of 60